Cat. No. | Product name | CAS No. |
DCC2289 |
Gne-783
Novel selective CHK1 inhibitor |
1200127-66-7 |
DCC2290 |
Gnf351
Novel potent aryl hydrocarbon receptor (AHR) antagonist with the capacity to inhibit both DRE-dependent and -independent activity |
1227634-69-6 |
DCC2292 |
Gnf-pf-3539
Novel Inhibitor of EGF-EGFR Interactions |
|
DCC2293 |
Gnf-pf-3600
Novel inhibitor of Plasmodium falciparum, killing both blood- and sexual-stage P. falciparum parasites |
|
DCC2294 |
gnf-pf-3834
Dose dependent up-regulator of the level of E-cadherin in SW620 cells |
64651-39-4 |
DCC2295 |
Gnidimacrin
Natural highly potent HIV latency-reversing agent |
60796-70-5 |
DCC2296 |
Gnlpt-in-1
Novel inhibitor of Gram-negative lipoprotein trafficking |
1639933-79-1 |
DCC2297 |
Gnmt Inducer K-117
Novel potent GNMT inducer, inhibiting Huh7 cell growth in vitro and xenograft in vivo |
|
DCC2298 |
Go/ldha-in-7
Dual Glycolate Oxidase/Lactate Dehydrogenase A (GO/LDHA) Inhibitor for Primary Hyperoxaluria |
|
DCC2299 |
Gonadorelin Acetate
Agonist of the GnRH receptor, inducing the secretion of the gonadotropins follicle-stimulating hormone and luteinizing hormone from the pituitary gland and to increase sex hormone production by the gonads |
71447-49-9 |
DCC2300 |
Gossypolone
Natural inhibitor of Musashi family of RNA-binding proteins |
4547-72-2 |
DCC2301 |
Govadine
Antipsychotic and cognitive enhancer; Dopamine D1 and D2 receptor modulator |
60383-78-0 |
DCC2302 |
Govaniadine
Natural potent inducer of apoptosis in MCF-7 cell lines |
|
DCC2303 |
Go-y030
Curcumin analog, exhibiting potent growth suppressive activity in human colorectal carcinoma cells |
917813-62-8 |
DCC2304 |
Gpbar1-agonist-10
Novel selective non-steroidal agonist of G-protein bile acid receptor 1 (GPBAR1, also known as TGR5 or M-BAR) |
|
DCC2305 |
Gpi-15427
Potent PARP inhibitor |
805242-85-7 |
DCC2306 |
Gpr120-agonist-6a
Novel potent GPR120 agonist, exhibiting significant glucose-lowering effect and high selectivity over GPR40 |
|
DCC2307 |
Gpr52-agonist-17
Novel potent GPR52 agonist, dose-dependently suppressing methamphetamine-induced hyperlocomotion in mice |
|
DCC2308 |
Gpr52-agonist-1b
The first orally active GPR52 agonist |
|
DCC2309 |
Gpr52-in-43
Highly potent and specific GPR52 antagonist |
|
DCC2310 |
Gpr88 Agonist 53
Novel, potent, efficacious, and brain-penetrant GPR88 agonist (cAMP EC 50 = 14 nM) |
|
DCC2311 |
Gpr88-agonist-84
Novel potent GPR88 agonist (EC 50 = 59 nM) |